Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Korean Journal of Veterinary Research ; : 261-263, 2014.
Article in English | WPRIM | ID: wpr-219579

ABSTRACT

A 10-year-old castrated male papillon presented with nasal discharge, coughing and chronic dysphagia. On physical examination, the dog exhibited sneezing, gurgling and movement of the throat with repeated attempts to swallow fluids. A diagnosis of cricopharyngeal achalasia (CPA) was made based on video fluoroscopic demonstration of failure of relaxation of the upper esophageal sphincter. This report describes the diagnosis of CPA in an old dog, which is rarely diagnosed in older animals.


Subject(s)
Animals , Child , Dogs , Humans , Male , Cough , Deglutition Disorders , Diagnosis , Esophageal Achalasia , Esophageal Sphincter, Upper , Pharynx , Physical Examination , Relaxation , Sneezing
2.
Korean Journal of Ophthalmology ; : 48-51, 2013.
Article in English | WPRIM | ID: wpr-19707

ABSTRACT

PURPOSE: To assess whether the expression of heat shock protein 72 (Hsp72) protects rat retinal ganglion cells (RGC-5) from apoptotic cell death. METHODS: Hsp72 expression in RGC-5 cells transduced with replication-deficient recombinant adenovirus was analyzed by Western blot analysis and immunofluorescence. The effect of Hsp72 expression on etoposide-induced apoptotic cell death was examined by microscopic analysis and confirmed by cell proliferation assay. RESULTS: Western blot analysis and immunofluorescence clearly showed adenovirus-mediated Hsp72 expression in RGC-5 cells. Treatment with etoposide resulted in the death of a proportion of the cells by apoptosis. However, this apoptotic cell death was significantly reduced in cells expressing Hsp72, with the reduction in cell death correlating to the level of Hsp72 expression. CONCLUSIONS: Over-expression of Hsp72 alone is sufficient to rescue neuronal cells from apoptotic cell death, suggesting that fine-tuning its expression may be an effective neuroprotective approach in retinal degenerative disease.


Subject(s)
Animals , Rats , Blotting, Western , Cell Death/genetics , Cell Survival , Cells, Cultured , DNA/genetics , Disease Models, Animal , Etoposide/toxicity , Gene Expression Regulation , HSP72 Heat-Shock Proteins/biosynthesis , Immunohistochemistry , Retinal Degeneration/genetics , Retinal Ganglion Cells/drug effects
3.
Experimental & Molecular Medicine ; : 303-309, 2012.
Article in English | WPRIM | ID: wpr-186639

ABSTRACT

We previously reported the successful establishment of embryonic stem cell (ESC)-like multipotent spermatogonial stem cells (mSSCs) from neonatal mouse testis. Here, we examined the ability of mSSCs to differentiate into vascular endothelial cells and smooth muscle cells, and compared to that of mouse ESCs. We used real-time reverse transcriptase polymerase chain reaction and immunohistochemistry to examine gene expression profiles of mSSCs and ESCs during in vitro vascular differentiation. Both mSSCs and ESCs exhibited substantial increase in the expression of mesodermal markers, such as Brachyury, Flk1, Mesp1, Nkx2.5, and Islet1, and a decrease in the expression of pluripotency markers, such as Oct3/4 and Nanog during the early stage of differentiation. The mRNA levels of vascular endothelial (VE)-cadherin and CD31 gradually increased in both differentiated mSSCs and ESCs. VE-cadherin- or CD31-positive cells formed sprouting branch-like structures, as observed during embryonic vascular development. At the same time, vascular smooth muscle cell-specific markers, such as myocardin and alpha-smooth muscle actin (SMA), were also highly expressed in differentiated mSSCs and ESCs. Immunocytochemical analysis revealed that the differentiated cells expressed both alpha-SMA and SM22-alpha proteins, and exhibited the intracellular fibril structure typical of smooth muscle cells. Overall, our findings showed that mSSCs have similar vascular differentiation abilities to those of ESCs, suggesting that mSSCs may be an alternative source of autologous pluripotent stem cells for vascular regeneration.


Subject(s)
Animals , Humans , Male , Mice , Animals, Newborn , Biomarkers/metabolism , Cell Differentiation/physiology , Embryonic Stem Cells/cytology , Endothelial Cells/cytology , Gene Expression , Gene Expression Profiling , Immunohistochemistry , Muscle, Smooth, Vascular/cytology , Myocytes, Smooth Muscle/cytology , Pluripotent Stem Cells/cytology , Real-Time Polymerase Chain Reaction , Spermatogonia/cytology , Testis/cytology
SELECTION OF CITATIONS
SEARCH DETAIL